Dermal Regeneration Market Report 2026

The dermal regeneration market size has grown strongly in recent years. It will grow from $1.79 billion in 2025 to $1.95 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising incidence of chronic wounds, growth in burn injury cases, increasing adoption of tissue engineering, expansion of hospital wound care units, improvement in biomaterial technologies.

The dermal regeneration market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing demand for minimally invasive skin repair, expansion of aesthetic and reconstructive surgery, rising aging population, increasing investment in regenerative medicine, advancement in cell based therapies. Major trends in the forecast period include rising adoption of bioengineered skin substitutes, increasing use of collagen and biomaterial scaffolds, growing demand for advanced wound healing therapies, expansion of regenerative treatments in burn care, higher utilization of dermal regeneration templates.

The rising incidence of burn injuries is anticipated to drive the growth of the dermal regeneration market in the coming years. Burn injuries involve damage to the skin or underlying tissues caused by heat, chemicals, electricity, radiation, or friction. The occurrence of burn injuries is increasing due to the widespread use of unsafe cooking fuels and appliances, including open flames and poorly maintained stoves, which elevate the risk of accidental fires and scalds, particularly in densely populated and low-income households. Burn injuries create a strong need for dermal regeneration solutions, as they require advanced skin repair and tissue restoration technologies to effectively treat moderate to severe skin damage. For instance, in January 2024, according to the Consumer Product Safety Commission (CPSC), a US-based federal agency, 11 deaths related to fireworks were reported, primarily due to misuse and device malfunctions. Additionally, an estimated 14,700 individuals sustained fireworks-related injuries, reflecting increases of approximately 38% in fatalities and 52% in injuries compared with 2023. Therefore, the growing incidence of burn injuries is contributing to the expansion of the dermal regeneration market.

Major companies operating in the dermal regeneration market are concentrating on the development of advanced products, such as collagen-based dermal matrices, to provide high biocompatibility and a reduced risk of immune rejection. A collagen-based dermal matrix is a scaffold primarily composed of collagen that supports new skin tissue formation and promotes wound healing. For instance, in January 2025, Fesarius Therapeutics Inc., a US-based biotechnology company, announced that it had received 510(k) clearance from the US Food and Drug Administration for its DermiSphere hydrogel Dermal Regeneration Template (DermiSphere hDRT). This product represents a new generation of collagen-based dermal matrices designed to enhance tissue integration, stimulate revascularization, and support effective wound healing. It is intended for applications in advanced wound care, reconstructive surgery, and regenerative medicine, offering an innovative approach with the potential to significantly advance dermal regeneration practices.

In August 2023, Coloplast, a Denmark-based medical device manufacturer, acquired Kerecis Limited for $1.3 billion. Through this acquisition, Coloplast strengthened its position in the biologics-based wound care and dermal regeneration market by incorporating Kerecis’s proprietary fish-skin graft technology. Kerecis Limited is a US-based manufacturer specializing in dermal regeneration products.

Major companies operating in the dermal regeneration market are Smith & Nephew Plc, Integra LifeSciences Corp., Organogenesis Inc., MiMedx Group Inc., Regenity Biosciences Inc., Avita Medical Inc., Polynovo, Symatese Co., Stratatech, MedSkin Solutions Dr. Suwelack AG, Japan Tissue Engineering Co. Ltd., CollPlant Biotechnologies Ltd., Holostem Terapie Avanzate.

North America was the largest region in the dermal regeneration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermal regeneration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dermal regeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the dermal regeneration market by increasing the cost of imported biomaterials, medical grade polymers, and tissue engineering equipment used in skin substitutes and scaffold production. These impacts have been most pronounced in north america and europe, where advanced wound care and regenerative therapies are widely adopted and rely on global supply chains. Hospitals, dermatology clinics, and ambulatory surgical centers have faced higher procurement costs for dermal regeneration products. However, tariffs have also encouraged domestic manufacturing of biomaterials and skin regeneration products, strengthening regional supply chains and supporting long term market growth.

The dermal regeneration market research report is one of a series of new reports that provides dermal regeneration market statistics, including dermal regeneration industry global market size, regional shares, competitors with a dermal regeneration market share, detailed dermal regeneration market segments, market trends and opportunities, and any further data you may need to thrive in the dermal regeneration industry. This dermal regeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dermal regeneration is the process of restoring and rebuilding the dermis, the deeper layer of the skin, following damage caused by injury, burns, or surgical procedures. It involves the repair of skin cells, blood vessels, and connective tissue to reestablish the skin’s normal structure and function. Dermal regeneration is commonly supported by specialized therapies that provide a structural framework for new tissue formation, helping to accelerate healing, reduce scarring, and enhance both the appearance and functionality of the skin.

The main product types used in dermal regeneration include skin substitutes, scaffolds, and others. Skin substitutes are medical products developed to replace or support damaged skin and are widely used in the treatment of burns, wounds, and post-surgical recovery. Key technologies involved include tissue engineering, cell-based therapies, biomaterial-based therapies, and other approaches, utilizing sources such as bovine collagen, silicone, and shark cartilage. Applications of dermal regeneration include chronic wounds, burn injuries, acute wounds, plastic and reconstructive surgery, and other uses, serving end users such as hospitals, dermatology and aesthetic clinics, specialty clinics, ambulatory surgical centers (ASCs), and others.

The dermal regeneration market consists of revenues earned by entities by providing services such as custom regeneration planning, post-treatment monitoring, tissue engineering collaboration services, and clinical data management. The market value includes the value of related goods sold by the service provider or included within the service offering. The dermal regeneration market also includes sales of collagen-based dressings, hydrogel dressings, antimicrobial dressings, and silicone sheets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.